Skip to main content
. 2009 Jun 29;20(2):67–71. doi: 10.3802/jgo.2009.20.2.67

Fig. 7.

Fig. 7

Protocol scheme of GCIG/JGOG 3017 for adjuvant chemotherapy for ovarian clear cell carcinoma patients eligibility: Patients with a pathologically confirmed clear cell carcinoma of the ovary. The histological diagnosis will be confirmed by central pathological review. Ages 18 or older, reasonable organ function.

PFS: progression-free survival, OS: overall survival